Effect of Mindfulness-based Psychoeducation in Depression
The Effect Of Mındfulness-Based Psychoeducatıon On Symptom Severıty, Stress Tolerance, And Emotıon Regulatıon Dıffıculty İn Patıents Dıagnosed Wıth Depressıon
1 other identifier
interventional
70
1 country
1
Brief Summary
Major depression is a mental illness that seriously threatens public health, leading to disability, reduced quality of life, economic burden, and premature death. It is estimated that 18.4% of the world's population lived with depression between 2005 and 2015, and it is projected to be a leading cause of global disease burden by 2030. Major depressive disorder manifests with symptoms such as decreased interest and desire, a depressed mood, increased or decreased sleep and appetite, feelings of worthlessness and guilt, decreased energy, suicidal thoughts and attempts, leading to significant impairment in functioning. Choosing the appropriate treatment for depression and taking measures to improve the individual's functionality quickly, shorten hospital stays, and reduce the number of hospitalizations are crucial. In addition to pharmacological treatment, clinical guidelines recommend the combined use of pharmacological and psychosocial interventions in the treatment of depression. The mindfulness-based cognitive therapy, which forms the basis of the psychoeducation planned for this study, was developed as an 8-week group approach. Theoretical studies examining emotion regulation mechanisms have indicated that mindful awareness is a fundamental mechanism for emotion regulation. The literature suggests a negative correlation between mindful awareness and the severity of depressive symptoms and difficulty in emotion regulation. Furthermore, despite numerous descriptive, correlational, and experimental studies on major depression, no studies have been found demonstrating the effect of mindful awareness-based psychoeducation on emotion regulation difficulties, distress tolerance, and symptom severity in patients diagnosed with major depression. This study, therefore, differs from existing research and will make a significant contribution to the literature.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 10, 2026
CompletedFirst Posted
Study publicly available on registry
March 20, 2026
CompletedStudy Start
First participant enrolled
April 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2027
March 20, 2026
March 1, 2026
1 month
March 10, 2026
March 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Beck Depression Inventory (BDI)
Beck Depression Inventory (BDI): Developed by Beck in 1961, the Beck Depression Inventory is designed to measure the risk of depression, the level of depressive symptoms, and variations in severity in adults. Consisting of 21 items, each item in the BDI has four options. Each item is scored between 0 and 3. The sum of these scores yields a depression score. The highest possible score is 63, and a higher total score indicates a higher severity of depression. In the Turkish adaptation of the BDI by Hisli (1988, 1989), the Cronbach α reliability coefficient was determined as α=0.80 in the validity and reliability study.
1.5 years
Secondary Outcomes (3)
Distress Tolerance Scale (DTS):
1.5 years
Personal Information Form
1.5 years
Difficulties in Emotion Regulation Scale (DDRS)
1.5 years
Study Arms (2)
control group
NO INTERVENTIONThe control group will be administered the pre-test scales. Participants will not receive any intervention. Then, the same scales will be administered as a post-test, and a follow-up test using the same scales will be conducted two months later.
experimental group
ACTIVE COMPARATORPre-test scales will be administered to participants in the experimental group. Participants will receive mindfulness-based psychoeducation. Then, post-test scales consisting of the same scales will be administered, and a follow-up test consisting of the same scales will be conducted 2 months later.
Interventions
The experimental group will receive an 8-session mindfulness-based psychoeducation program, administered twice a week for four weeks. Each session of the eight-week program will be 45-60 minutes long. Sessions will be conducted in groups. Following an initial face-to-face meeting to inform the experimental group about the program and schedule meetings, the sessions will continue in person. Each group will consist of 7 people, with a total of 5 groups. Patients will be contacted by phone before each session to remind them of the program time. Immediately after the program sessions are completed, the experimental group will take a post-test. Additionally, follow-up tests will be administered two months after the program is completed. The control group will receive a pre-test followed by no intervention; a post-test will be administered two months later, and follow-up tests two months after the post-test.
Eligibility Criteria
You may qualify if:
- Volunteering to participate in the study
- Residing in Gaziantep city center
- Not having any communication impediments
- Being between 18 and 65 years of age
- Being followed up as an outpatient with a diagnosis of depression according to DSM-V criteria
- Having been receiving treatment for depression for at least 6 months
- Being literate
- Not having been enrolled in such an educational program related to their illness within the last 5 years
You may not qualify if:
- Those diagnosed with another comorbid mental illness
- Patients with mental conditions that make cooperation impossible, such as intellectual disability or dementia
- Those who are illiterate
- Patients who do not consent to the interview
- Those receiving inpatient treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gaziantep Üniversitesi
Gaziantep, şehitkamil, 34000, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participants in the experimental group will receive mindfulness-based psychoeducation, and the results will be evaluated by the researcher.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- specialist nurse
Study Record Dates
First Submitted
March 10, 2026
First Posted
March 20, 2026
Study Start
April 1, 2026
Primary Completion (Estimated)
May 1, 2026
Study Completion (Estimated)
October 1, 2027
Last Updated
March 20, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
Individual patient data will not be shared in order to protect patient privacy and avoid stigmatization.